Market Research Logo

North America Glucose Monitoring System Market Forecast 2018-2026

North America Glucose Monitoring System Market Forecast 2018-2026

KEY FINDINGS
The North America glucose monitoring system market accounted for the highest revenue share of the global market in 2017. Over the predicted years of 2018-2026, the CGMS market is expected to witness a CAGR of 30.19%, generating total revenue of $6115.5 million. Meanwhile, the SMBG market is expected to grow at 5.34% CAGR while generating a total revenue of $10528.1 million, by the end of the said forecast period.

MARKET INSIGHTS
Prevalence rates of diabetes in North America are in the range of 9% to 12%, that is close to the top of the global scale. The U.S is the largest national diabetes market and Canada’s share in the global market is far greater than its population. Governments are strategizing several initiatives for the prevention of diabetes in the country and creating awareness among people with regular diabetes screenings, lifestyle counselling, and diabetes education, with no out of pocket costs. The diabetic products are also provided online and that too at discounted rates. The administrations are also making sure that all the individuals, especially in Canada, are covered for medically necessary physician and hospital series.

COMPETITIVE INSIGHTS
PharmaTech, LifeScan, Bayer, Abbott, Sanofi, Roche, OneTouch, Medtronic Inc., DexCom, Johnson & Johnson, Insulet Corp, Tandem Diabetes Care Inc., and Echo Therapeutics are some of the leading companies in this region.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Study Market
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.2. Bottom-up Approach
2.3. Top Down Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Cgms Market Is Anticipated To Be The Developed Market
3.2.2. Self-monitoring Of Blood Glucose Has Huge Market Opportunity
3.2.3. Collaboration Of Significant Companies To Develop Integrated Cgms-enabled Insulin Pumps
4. Market Overview
4.1. Drivers And Impact
4.1.1. Rise In The Incidence Of Diabetes
4.1.2. Increase In Healthcare Expenditure
4.1.3. Increasing Focus On Research And Development
4.1.4. Technology Integration
4.1.5. Increasing Cgms And Smbg Affordability
4.1.6. Technological Advances In Gms Devices
4.1.7. Awareness Among The General Population
4.2. Restrain And Impact
4.2.1. Hinderance From Government Regulations
4.2.2 Inadequate Reimbursement Options For Continuous Glucose Monitoring Devices
4.2.3. Lack Of Awareness Of The Diagnostic Opportunities
4.3. Challenges
4.3.1. Intense Competition Among Vendors
4.3.2. Inaccuracy In Reading Of Gms Devices
4.3.3. Increasingly Stringent Government Regulations
5. Cgms Market Segmentation
5.1. Market By Component Type 2018-2026
5.1.1. Sensors
5.1.2. Transmitters And Receivers
5.1.3. Insulin Pump
5.2. Market By End Users 2018-2026
5.2.1. Home Settings
5.2.2. Diagnostics And Clinics
5.2.3. Hospitals
6. Smbg Market
7. Smbg Market Segmentation
7.1. Market By Component Type 2018-2026
7.1.1. Test Strips
7.1.2. Glucose Meter
7.1.3. Lancets
7.2. Market By End Users 2018-2026
7.2.1. Home Settings
7.2.2. Clinics
7.2.3. Hospitals
8. Key Analytical
8.1. 5 Forces Analysis
8.1.1. Threat Of New Entrant
8.1.2. Threat Of Substitute Products Or Services
8.1.3. Bargaining Power Of Buyers
8.1.4. Bargaining Power Of Supplier
8.1.5. Intensity Of Competitive Rivalry
8.2. Merger And Acquisitions
8.3. Key Buying Criteria
8.4. Key Trends
8.4.1. Development Of High-quality Wearable Devices
8.4.2. Mobile Healthcare Making The Devices More User-friendly
8.4.3. Increasing Efforts Towards Spread Of Awareness
8.4.4. Increase In Non-invasive Devices
8.4.5. Energy Harvesting Technology For Uninterrupted Usage
8.5. Regulation Of Blood Sugar
8.6. Incidence And Prevalence Of Diabetes For Various Countries
9. Regional Analysis
9.1. North America
9.1.1. The Us
9.1.1.1. The United States Health And Healthcare
9.1.1.2. The United States Pharmaceutical Market
9.1.2. Canada
9.1.2.1. Canada Health And Healthcare
9.1.2.2. Canada Pharmaceutical Market
9.1.2.3. Canada Diabetes Market
10. Competitive Landscape
10.1. Medtronic
10.1.1. Overview
10.1.2. Product Portfolio
10.1.3. Strategic Initiatives
10.1.4. Scot Analysis
10.2. Dexcom
10.2.1. Overview
10.2.2. Product Portfolio
10.2.3. Strategic Initiatives
10.2.4. Scot Analysis
10.3. Abbott
10.3.1. Overview
10.3.2. Product Portfolio
10.3.3. Strategic Initiatives
10.3.4. Scot Analysis
10.4. Johnson And Johnson
10.4.1. Overview
10.4.2. Product Portfolio
10.4.3. Strategic Initiatives
10.4.4. Scot Analysis
10.5. Insulet Corp
10.5.1. Overview
10.5.2. Product Portfolio
10.5.3. Strategic Initiatives
10.5.4. Scot Analysis
10.6. Tandem Diabetes Care
10.6.1. Overview
10.6.2. Product Portfolio
10.6.3. Strategic Initiatives
10.6.4. Scot Analysis
10.7. Echo Therapeutics Inc
10.7.1. Overview
10.7.2. Product Portfolio
10.7.3. Strategic Initiatives
10.7.4. Scot Analysis
10.8. Roche Diagnostics
10.8.1. Overview
10.8.2. Product Portfolio
10.8.3. Strategic Initiatives
10.8.4. Scot Analysis
10.9. Nemaura Medical Inc
10.9.1. Overview
10.9.2. Product Portfolio
10.9.3. Strategic Initiatives
10.9.4. Scot Analysis
10.10. Senseonics Inc
10.10.1. Overview
10.10.2. Product Portfolio
10.10.3. Strategic Initiatives
10.10.4. Scot Analysis
10.11. Glysens Inc
10.11.1. Overview
10.11.2. Product Portfolio
10.11.3. Strategic Initiatives
10.11.4. Scot Analysis
10.12. Terumo
10.12.1. Overview
10.12.2. Product Portfolio
10.12.3. Strategic Initiatives
10.12.4. Scot Analysis
10.13. Wockhardt
10.13.1. Overview
10.13.2. Product Portfolio
10.13.3. Strategic Initiatives
10.13.4. Scot Analysis
10.14. I-sens Inc
10.14.1. Overview
10.14.2. Product Portfolio
10.14.3. Strategic Initiatives
10.14.4. Scot Analysis
10.15. Morpen Laboratories Ltd.
10.15.1. Overview
10.15.2. Product Portfolio
10.15.3. Startegic Initiative
10.15.4. Scot Analysis
10.16. Apex Biotechnology Corp.
10.16.1. Overview
10.16.2. Product Portfolio
10.16.3. Scot Analysis
10.17. Arkray Inc
10.17.1. Overview
10.17.2. Product Portfolio
10.17.3. Strategic Analysis
10.17.4. Scot Analysis
10.18. B Braun Melsungen Ag
10.18.1. Overview
10.18.2. Product Portfolio
10.18.3. Scot Analysis
10.18.4. Strategic Analysis
10.19. Ascensia
10.19.1. Overview
10.19.2. Product Portfolio
10.19.3. Scot Analysis
10.19.4. Strategic Analysis
Table List
Table 1 North America Cgms Market, 2018-2026($ Million)
Table 2 North America Smbg Market, 2018-2026 ($ Million)
Table 3 North America Cgms Market, By Component Type, 2018-2026($ Million)
Table 4 North America Cgms Sensors Market, 2018-2026 ($ Million)
Table 5 North America Cgms Transmitters And Receivers Market, 2018-2026 ($ Million)
Table 6 North America Cgms Insulin Pump Market, 2018-2026 ($ Million)
Table 7 North America Cgms Market, By Application 2018-2026 ($ Million)
Table 8 North America Cgms Home Settings Market, 2018-2026 ($ Million)
Table 9 North America Cgms Diagnostics And Clinical Market, 2018-2026 ($ Million)
Table 10 North America Cgms Hospital Market, 2018-2026 ($ Million)
Table 11 Important Aspects For Use Of Smbg Devices In Home-care Settings
Table 12 Smbg Strips Usage Scenario In Selected Countries In Americas
Table 13 Product Matrix For Lancets
Table 14 North America Smbg Market, By Component Type, 2018-2026 ($ Million)
Table 15 North America Smbg Lancets Market, 2018-2026 ($ Million)
Table 16 North America Smbg Home Setting Market, 2018-2026 ($ Million)
Table 17 North America Smbg Clinical Market, 2018-2026 ($ Million)
Table 18 North America Smbg Hospitals Market, 2018-2026 ($ Million)
Table 19 North America Smbg Market, 2018-2026 ($ Million)
Table 20 North America Smbg Market 2018-2026 ($ Million)
Table 21 North America Cgms Market 2018-2026 ($ Million)
Figures List
Figure 1 North America Cgms Sensors Market, 2018-2026($ Million)
Figure 2 North America Cgms Transmitters And Receivers Market, 2018-2026($ Million)
Figure 3 North America Cgms Insulin Pump Market, 2018-2026($ Million)
Figure 4 North America Cgms Share, By Application 2017 & 2026 (%)
Figure 5 North America Cgms Home Setting Market, 2018-2026($ Million)
Figure 6 North America Cgms Diagnostics And Clinical Market, 2018-2026($ Million)
Figure 7 North America Cgms Hospital Market, 2018-2026($ Million)
Figure 8 North America Smbg Market Share, By Component Type 2017 & 2026(%)
Figure 9 North America Smbg Test Strips Market, 2018-2026 ($ Million)
Figure 10 North America Smbg Test Strips Market, 2018-2026 ($ Million)
Figure 11 North America Smbg Glucose Meter Market, 2018-2026 ($ Million)
Figure 12 North America Smbg Glucose Meter Market, 2018-2026 ($ Million)
Figure 13 North America Smbg Lancets Market, 2018-2026 ($ Million)
Figure 14 North America Smbg Market Share, By Application 2017& 2026(Us $ Million)
Figure 15 North America Smbg Home Setting Market, 2018-2026 ($ Million)
Figure 16 North America Smbg Clinical Market, 2018-2026 ($ Million)
Figure 17 North America Smbg Hospitals Market, 2018-2026 ($ Million)
Figure 18 North America Ggms Market Share, 2017 & 2026 (%)
Figure 19 North America Cgms Market Share, By Country 2017 & 2026 (%)
Figure 20 Us Cgms Market Revenue, 2018-2026($ Million)
Figure 21 Us Smbg Market Revenue, 2018-2026($ Million)
Figure 22 Canada Cgms Market Revenue, 2018-2026 ($ Million)
Figure 23 Canada Smbg Market Revenue, 2018-2026 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report